Source: Investor Presentation of Tracxn Technologies Ltd

Some stuff I am reading today morning:
Fitch downgrades US long term rating (CNBC)
Tax Filing for AY24 touches all time high (BS)
Can Jio Financial disrupt the Mutual Fund business? (Money Life)
Vanguard marks down Ola by 50% (MC)
Tiger Global’s bets in India (Forbes)
Company: Eveready (FE)
Startup: Statiq (BI)
Yes, its a bubble (Daily Reckoning)
7 things I don’t own in my portfolio (Morningstar)
The greatest investment quotes (Of $ and Data)
Source: RHP of Concord Biotech Ltd
The IPO of Concord Biotech Ltd is expected to open shortly.
One of the interesting aspects of this co is that marquee investors like Late Rakesh Jhunjhunwala,Amal Parikh etc had invested in the co way back in 2004.
Using Amal Parikh as an example, it would be interesting to see the kind of returns this investment generated.
On 13 Dec, 2004, Amal Parikh bought 25,000 shares @ 359.55 Rs/share i.e an investment of Rs.89,88,750 /-

Numerous bonuses,splits etc later, the shareholding of Amal Parikh increased from 25,000 shares to 20,23,219 shares.

At the upper ipo price band of Rs. 741 per share, this translates to an amount of Rs. 149,92,05,279 /-
The CAGR return over 19 years is a whopping 30.9% CAGR !